FLG, FLG2, RPTN and SPRR1A together might be considered potential candidate biomarkers for differential diagnosis in AD and CTCL using either PCR or ELISA method. The gene discussed is FLG; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.